Open AccessRisk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus
Author(s) -
Darren Jun Hao Tan,
Cheng Han Ng,
Phoebe Wen Lin Tay,
Nicholas Syn,
Mark Muthiah,
Wen Hui Lim,
Ansel Shao Pin Tang,
Kai En Lim,
Grace En Hui Lim,
Nobuharu Tamaki,
Beom Kyung Kim,
Margaret Teng,
James Fung,
Rohit Loomba,
Mindie H. Nguyen,
Daniel Q. Huang
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.19407
Subject(s) - entecavir , medicine , hepatocellular carcinoma , propensity score matching , hazard ratio , meta analysis , tenofovir , proportional hazards model , hepatitis b virus , oncology , confidence interval , virology , lamivudine , virus , human immunodeficiency virus (hiv)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom